Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroders Regulatory News (SOI)

Share Price Information for Schroders (SOI)

Share Price is delayed by 15 minutes
Get Live Data
433.00    -16.00 (-3.56%)
Bid:
433.00
Ask:
435.50
Spread: 2.50 (0.577%)
Market Cap: £967.63m
SOI Live PriceLast checked at - London Stock Exchange

Intraday Schroders Share Chart

Results analysis from Kepler Trust Intelligence

24 May 2024 09:58

RNS Number : 8379P
Schroder Oriental Income Fund Ltd
24 May 2024
 

Schroder Oriental Income (SOI)

24/05/2024

Results analysis from Kepler Trust Intelligence

Schroder Oriental Income (SOI) has released its interim results for the period ending 29/02/2024. Over the period, the trust saw its NAV increase by 7.5% on a total return basis, which compares to a return of 1.9% for the MSCI AC Pacific ex Japan Index, the trust's formal benchmark. The AIC Asia Pacific Equity Income sector delivered a weighted average return of 5.8% over the same period.

The top performers in the period have been the region's technology firms. This has been driven by the industry's destocking trend and the increased proliferation of artificial intelligence. Richard's stock selection has led to an overweight which has been beneficial to performance.

Richard has an underweight allocation to China which has been a big contributor to performance following the country's challenges. However, the manager still generated positive alpha from China. Richard has an overweight to Hong Kong which was a drag on returns, though this was more than offset by strong stock selection leading to a positive overall return.

Two interim dividends were declared in the period. Earnings growth has been modest in the region, though Richard believes this could begin to pick up. He is confident that underlying income remains robust enough to maintain the trust's strong progressive dividend track record.

The discount widened during the period from 4.5% to 6.4%, though this has narrowed in the period post the interim statement.

The trust's chair, Paul Meader, reflected on the positive long-term outperformance of the trust stating: "Since inception, a shareholder has received a total return of 489.0%, whereas a passive investment in the Reference Index would have generated 288.5%"

Kepler View

We believe this interim statement is another demonstration of the benefits of active management in Asia, and a testament to Richard's stock selection approach. Whilst the region has been overshadowed by global equities, Richard has delivered significant outperformance, strong absolute returns and a diversified income source.

Performance has primarily been driven by stock selection. This has been particularly impressive in the China and Hong Kong allocations in our opinion. Richard is underweight China, which aided relative performance, yet the companies he did hold have outperformed. Meanwhile, he his overweight Hong Kong which was a drag on performance, yet this was more than offset by positive stock selection. We believe this should provide investors with confidence in Richard's ability to outperform over the long-term.

Richard highlights that aggregate valuations are back in line with long-term averages, though there is significant dispersion which lends itself well to his active approach. He notes that the region's prospects could be affected by changes in the interest rate cycle in developed markets. We would expect this to be beneficial company earnings, providing support for the income picture also.

SOI's dividend outlook remains strong, supported by the trust's large financials allocation. The trust has an impressive dividend growth track record and Richard believes the outlook supports this. We believe SOI continues to provide investors with a diversified income stream to traditional asset classes.

Despite the strong performance in the period, the discount widened in the period which Richard believes reflects the negative sentiment towards Asia which could arguably reverse. We believe the discount offers investors a potentially attractive entry point.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

 

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAKZGZKRDKGDZG
Date   Source Headline
5th Jun 20265:06 pmRNSTransaction in Own Shares
5th Jun 202611:35 amRNSNet Asset Value(s)
4th Jun 20265:40 pmRNSTransaction in Own Shares
4th Jun 202611:32 amRNSNet Asset Value(s)
3rd Jun 20265:01 pmRNSTransaction in Own Shares
3rd Jun 202611:16 amRNSNet Asset Value(s)
2nd Jun 202612:00 pmRNSNet Asset Value(s)
1st Jun 202611:48 amRNSNet Asset Value(s)
29th May 20265:42 pmRNSTotal Voting Rights
29th May 20265:25 pmRNSTransaction in Own Shares
29th May 202611:33 amRNSNet Asset Value(s)
28th May 20265:36 pmRNSTransaction in Own Shares
28th May 202611:37 amRNSNet Asset Value(s)
27th May 20265:07 pmRNSDirector/PDMR Shareholding
27th May 202611:26 amRNSNet Asset Value(s)
26th May 202611:55 amRNSNet Asset Value(s)
22nd May 202611:35 amRNSNet Asset Value(s)
22nd May 20269:28 amRNS-RResults analysis from Kepler Trust Intelligence
21st May 202610:56 amRNSNet Asset Value(s)
21st May 20267:00 amRNSHalf-year Report
20th May 202611:32 amRNSNet Asset Value(s)
19th May 20265:18 pmRNSTransaction in Own Shares
19th May 202611:35 amRNSNet Asset Value(s)
18th May 20265:21 pmRNSTransaction in Own Shares
18th May 202611:36 amRNSNet Asset Value(s)
15th May 20265:16 pmRNSTransaction in Own Shares
15th May 202611:43 amRNSNet Asset Value(s)
14th May 20265:13 pmRNSTransaction in Own Shares
14th May 202611:44 amRNSNet Asset Value(s)
13th May 20265:10 pmRNSTransaction in Own Shares
13th May 202611:35 amRNSNet Asset Value(s)
12th May 20265:23 pmRNSTransaction in Own Shares
12th May 20264:53 pmRNSPortfolio Update
12th May 202611:13 amRNSNet Asset Value(s)
11th May 20265:16 pmRNSTransaction in Own Shares
11th May 202611:51 amRNSNet Asset Value(s)
8th May 202611:50 amRNSNet Asset Value(s)
7th May 202611:50 amRNSNet Asset Value(s)
6th May 202611:39 amRNSNet Asset Value(s)
5th May 202611:17 amRNSNet Asset Value(s)
1st May 202611:55 amRNSNet Asset Value(s)
1st May 202611:14 amRNSTotal Voting Rights
30th Apr 202611:45 amRNSNet Asset Value(s)
29th Apr 20265:13 pmRNSTransaction in Own Shares
29th Apr 202610:59 amRNSNet Asset Value(s)
28th Apr 20265:15 pmRNSTransaction in Own Shares
28th Apr 202611:45 amRNSNet Asset Value(s)
27th Apr 202611:17 amRNSNet Asset Value(s)
24th Apr 202612:49 pmRNSNet Asset Value(s)
23rd Apr 202612:01 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.